Found 5 matching trials
Bioequivalence Study of Solifenacin Succinate & Mirabegron From Mirfenacin MR 5/50 mg Extended Release Tablets (Hikma Pharma, Egypt) Versus Vesicare 5 mg FCT & Betmiga 50 mg Prolonged-Release Tablets (Astellas Pharma Europe B.V, the Netherlands / Astellas Pharma Europe B.V, the Netherlands) PHASE1 An open label randomized, single dose, three-way, partial replicate bioequi...
Show More Location
Genuine Research Center GRC
Learn More & Join Trial
Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder PHASE3 The study is intended to test the safety, tolerability, efficacy of two dos...
Show More Location
Multiple Locations
Learn More & Join Trial
Comparative Study Between Behavior Therapy and Behavior Therapy Plus Mirabegron in Sexually Active Men With OAB Symptoms NA The objective of this study is to evaluate and compare the therapeutic effe...
Show More Location
Chang Gung Memorial Hospital, Chang Gung University College of Medicine
Learn More & Join Trial
A Study to Evaluate Tolerability and Participants Preference Between Mirabegron and Tolterodine Extended Release (ER) in Participants With Overactive Bladder (OAB) PHASE4 The purpose of this study was to assess tolerability of mirabegron compared...
Show More Location
Site US10002 Urology Centers of Alabama
Learn More & Join Trial
Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity PHASE3 The objective of the study was to evaluate the efficacy, safety, tolerabili...
Show More Learn More & Join Trial